Across TCGA pan-cancer cohorts, RPL32P19 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL32P19’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPL32P19 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL32P19 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD and THCA are the cancer types where RPL32P19 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P19 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	−0.046	.009	4	view →
THCA	All	All	+0.020	.006	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPL32P19 RNA expression & survival · all RPL32P19 data types